Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Next generation sequencing analysis in Y-1 mouse adrenocortical cells after dexamethasone treatment

ABSTRACT: Next generation sequencing analysis in Y-1 mouse adrenocortical cells after dexamethasone treatment

PROVIDER: PRJNA782501 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16999824_1.fastq.gz	Fastqsanger.gz
	SRR16999824_2.fastq.gz	Fastqsanger.gz
	SRR16999825_1.fastq.gz	Fastqsanger.gz
	SRR16999825_2.fastq.gz	Fastqsanger.gz
	SRR16999826_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Next generation sequencing analysis in Y-1 mouse adrenocortical cells after dexamethasone treatment

Project description:RNA sequencing (RNA-seq) was used to identify early transcriptomic responses of Y-1 cells to the dexamethasone treatment.

2022-07-07 | GSE189305 | GEO

Next generation sequencing analysis of mouse adrenal glands after a one-hour dexamethasone treatment

Project description:Next generation sequencing analysis of mouse adrenal glands after a one-hour dexamethasone treatment

| PRJNA781856 | ENA

Next Generation Sequencing Facilitates Quantitative Analysis of Transcriptomes Caused by Dexamethasone Treatment in Cancer Cells

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of Transcriptomes Caused by Dexamethasone Treatment in Cancer Cells

| PRJNA554267 | ENA

Next Generation Sequencing Facilitates Quantitative Analysis of Transcriptomes Caused by Dexamethasone Treatment in Cancer Cells

Project description:As commonly used drug in clinical, there is little known about the effects of dexamethasone (Dex) on cancer cells. The goals of this study are to explore the transcriptome caused by Dex in cancer cells. Seven cancer cell lines were used in this project, gastric cancer cell lines SGC-7901 and MKN-45, and colorectal cancer cell lines NCIH-747 and RKO, liver cancer cell line SMMC-7721, pancreatic cancer cell line BxPC3, melanoma cell line MV3. After treated by Dex for 48 hours, total RNAs were extracted for next-generation sequencing profiling.

2021-07-12 | GSE134195 | GEO

Expression data from H295R_GRα cells following treatment with dexamethasone or RU486

Project description:The human glucocorticoid receptor (GRα) is overexpressed at the molecular and protein level in malignant human adrenocortical cancers. A stable cell line model of GRα overexpression was established using the H295R human adrenocortical cancer cell line. The following results were obtained from gene expression profiling of H295R_GRα and H295R_Control (empty vector) cells following treatment with either a GRα agonist (dexamethasone), GRα antagonist (RU486) or vehicle (ethanol) control.

2015-01-10 | GSE64826 | GEO

Expression data from H295R_GRÎ± cells following treatment with dexamethasone or RU486

Project description:The human glucocorticoid receptor (GRÎ±) is overexpressed at the molecular and protein level in malignant human adrenocortical cancers. A stable cell line model of GRÎ± overexpression was established using the H295R human adrenocortical cancer cell line. The following results were obtained from gene expression profiling of H295R_GRÎ± and H295R_Control (empty vector) cells following treatment with either a GRÎ± agonist (dexamethasone), GRÎ± antagonist (RU486) or vehicle (ethanol) control. H295R_GRÎ± and H295R_Control (empty vector) cells were treated in triplicate for 6 hours with dexamethasone 100 nM, RU486 100 nM or vehicle (ethanol) control.

2015-01-10 | E-GEOD-64826 | biostudies-arrayexpress

Next generation sequencing analysis of mouse adrenal glands after a one-hour dexamethasone treatment

Project description:RNA sequencing (RNA-seq) was used to identify early transcriptomic responses of the adrenal gland to the 1-hour dexamethasone treatment in mice.

2022-07-07 | GSE189182 | GEO

Dexamethasone treatment alters levels of insulin, leptin, and adiponectin but does not have metabolic effects across generations

Project description:Genome-wide expression analysis of sperms did not identify significant transcriptome changes upon dexamethasone treatment in mice. These results are consistent with the observation that dexamethasone treatment of parental male mice did not induce metabolic changes in the F1 generation.

2015-11-25 | GSE67290 | GEO

Rat liver: Dexamethasone treatment vs. Control

Project description:Sixteen male Sprague-Dawley rats were randomly allocated into 2 groups (8 rats per group) as follows: the control group (CON) and the dexamethasone-treated group (DEXA). Dexamethasone-treated rats received a daily intraperitoneal injection of 1.5 mg/kg of dexamethasone for 5 days. All rats were fasted during the night following the fifth day. On the sixth day, the animals were killed by decapitation. In order to focus our investigation on metabolism-related genes, we developed a metabolism dedicated microarray tool: the Mitoligo. Using this microarray tool, we were able to determine that energy metabolism was deeply modified by dexamethasone treatment. Dexamethasone treatment to rats induces a complete switch of the metabolism toward a maximal rate of ATP synthesis. In this study, we show that substrate supplying for oxidative phosphorylation is greatly enhanced. We also confirm that oxidative phosphorylation capacity is increased by dexamethasone treatment. Keywords: hormonal treatment

2008-01-13 | GSE9035 | GEO

Development and validation of Next-Generation Sequencing panel for personalized Helicobacter pylori eradication treatment

Project description:Development and validation of Next-Generation Sequencing panel for personalized Helicobacter pylori eradication treatment

2024-08-19 | PRJEB79130 | EVA